发明名称 Antibodies for botulinum neurotoxins
摘要 The present disclosure provides antibodies that specifically bind to botulinum neurotoxins (e.g., BoNT/A, BoNT/B, BoNT/C, BoNT/D, BoNT/E, BoNT/F, BoNT/G, etc.) and the epitopes bound by those antibodies. The antibodies and derivatives thereof that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.
申请公布号 US9243057(B2) 申请公布日期 2016.01.26
申请号 US201113813623 申请日期 2011.08.31
申请人 The Regents of the University of California 发明人 Marks James D.;Consuelo Garcia Rodriguez Maria
分类号 C07K16/12;G01N33/569;G01N33/573;A61K39/00 主分类号 C07K16/12
代理机构 Bozicevic, Field & Francis LLP 代理人 Francis Carol L.;Davy Brian E.;Bozicevic, Field & Francis LLP
主权项 1. An isolated antibody, or antigen-binding fragment thereof, that competes for binding with, or specifically binds an epitope of a Botulinum neurotoxin that is specifically bound by, an antibody comprising: a) a VH CDR1 comprising the amino acid sequence of residues 31-35 of SEQ ID NO:68; b) a VH CDR2 comprising the amino acid sequence of residues 50-66 of SEQ ID NO:68; c) a VH CDR3 comprising the amino acid sequence of residues 99-114 of SEQ ID NO:68; d) a VL CDR1 comprising the amino acid sequence of residues 24-34 of SEQ ID NO:205; e) a VL CDR2 comprising the amino acid sequence of residues 50-56 of SEQ ID NO:205; and f) a VL CDR3 comprising the amino acid sequence of residues 89-97 of SEQ ID NO:205.
地址 Oakland CA US